RAPT logo

RAPT Therapeutics (RAPT)

Profile

Full Name

RAPT Therapeutics, Inc.

Ticker Symbol

RAPT

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

October 31, 2019

Indexes

Not included

Website

http://www.rapt.com

Employees

68

Key Details

Price

$0.86(-7.45%)

Market cap

$113.13M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$3.19(-4.59% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.86
RAPT price is $0.86

30-Day Relative Volume

1.07
RAPT 30-day relative volume is 1.07

Price Performance

Price Most recent change

-7.45%
RAPT price was down -7.45% on Apr 15, 2025

Price YTD change

-45.76%
RAPT price is down -45.76% since January 1st

Price 1-year change

-89.96%
RAPT price is down -89.96% year-on-year

Price 3-year change

-95.88%
RAPT price is down -95.88% over the past 3 years

Price Range

Price All-time high

$51.21
RAPT price is currently -98.33% below its historical high of $51.21

Price 3-year low

$0.79
RAPT price is currently +8.62% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$113.13M
RAPT market capitalization is $113.13 million

Market cap 3-year change

-81.63%
RAPT market capitalization is down -81.63% over the past 3 years

Market cap All-time high

$1.19B
RAPT market capitalization is currently -90.48% below its historical high of $1.19 billion

Market cap sector rank

50%
RAPT market capitalization is higher than 50% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+279.33%
RAPT shares outstanding is up +279.33% year-on-year

Shares Outstanding 3-Year Change

+346.08%
RAPT shares outstanding is up +346.08% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.38
RAPT beta is 1.38

200-day SMA

$1.76
RAPT price is currently -51.17% below its 200-day simple moving average

50-day SMA

$1.15
RAPT price is currently -25.59% below its 50-day simple moving average

RSI

33.93
RAPT 14-day relative strength index is 33.93

Volume

1.07
RAPT 30-day relative volume is 1.07

ATR

$0.10
RAPT average true range is $0.10

10-day Historical Volatility

85.47%
RAPT 10-day historical volatility is 85.47%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
RAPT annual revenue value is unknown

Revenue Analysts estimate

-
RAPT annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
RAPT annual revenue 1-year change is unknown

Revenue Sector rank

-
RAPT annual revenue is unknown

EPS

EPS

-$3.19
RAPT annual earnings per share is -$3.19

EPS Analysts estimate

-$0.60
RAPT annual earnings per share is currently +434.79% higher than the consensus analysts' forecast

EPS 1-year change

-4.59%
RAPT annual earnings per share is down -4.59% year-on-year

EPS Sector rank

27.92%
RAPT annual earnings per share is higher than 27.92% of companies in Healthcare sector

Profit

Gross profit

-
RAPT annual gross profit value is unknown

Gross margin

-
RAPT annual gross profit margin value is unknown

Operating profit

-$136.10M
RAPT annual operating income is -$136.10 million

Operating margin

-
RAPT annual operating profit margin value is unknown

Net income

-$129.87M
RAPT annual net profit is -$129.87 million

Net margin

-
RAPT annual net profit margin value is unknown

Expenses

Total expenses

$136.10M
RAPT annual total expenses is $136.10 million

Operating expenses

$136.10M
RAPT annual total operating expenses is $136.10 million

Cost of goods sold

-
RAPT annual cost of goods sold value is unknown

Selling, general & administrative expenses

$28.88M
RAPT annual SGA is $28.88 million

Depreciation and amortization

$1.20M
RAPT annual depreciation & amortization is $1.20 million

Interest expense

-
RAPT annual interest expense value is unknown

Income tax

-
RAPT annual income tax value is unknown

EBIT & EBITDA

EBIT

-$136.10M
RAPT annual earnings before interest & taxes is -$136.10 million

EBITDA

-$134.90M
RAPT annual EBITDA is -$134.90 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$240.32M
RAPT annual total assets is $240.32 million

Non current assets

$5.09M
RAPT annual long term assets is $5.09 million

Current assets

$235.24M
RAPT annual total current assets is $235.24 million

Cash and cash equivalents

$169.74M
RAPT annual cash & cash equivalents is $169.74 million

Accounts receivable

-
RAPT annual accounts receivable value is unknown

Inventory

-
RAPT annual inventory value is unknown

Liabilities

Total liabilities

$50.42M
RAPT annual total liabilities is $50.42 million

Long term liabilities

$2.07M
RAPT annual total long term liabilities is $2.07 million

Current liabilities

$48.35M
RAPT annual total current liabilities is $48.35 million

Accounts payable

$1.27M
RAPT annual accounts payable is $1.27 million

Debt

Total debt

$4.49M
RAPT annual total debt is $4.49 million

Total debt 1-year change

-34.96%
RAPT annual total debt is down -34.96% year-on-year

Long term debt

$2.07M
RAPT annual long term debt is $2.07 million

Short term debt

$2.42M
RAPT annual short term debt is $2.42 million

Equity & Capital

Shareholders equity

$189.90M
RAPT annual stockholders equity is $189.90 million

Book value

$189.90M
RAPT annual book value is $189.90 million

Retained earnings

-$614.55M
RAPT annual retained earnings is -$614.55 million

Working capital

$186.88M
RAPT annual working capital is $186.88 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$83.30M
RAPT annual cash flow from operations is -$83.30 million

Cash from operations 1-year change

+14.17%
RAPT annual cash flow from operations is up +14.17% year-on-year

Cash from investing

$52.70M
RAPT annual cash flow from investing activities is $52.70 million

Cash from investing 1-year change

-49.39%
RAPT annual cash flow from investing activities is down -49.39% year-on-year

Cash from financing

$152.85M
RAPT annual cash flow from financing activities is $152.85 million

Cash from financing 1-year change

+10463.37%
RAPT annual cash flow from financing activities is up +10463.37% year-on-year

CAPEX

CAPEX

-
RAPT annual capital expenditures value is unknown

CAPEX 1-year change

-
RAPT annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$83.42M
RAPT annual free cash flow is -$83.42 million

Free cash flow 1-year change

+15.03%
RAPT annual free cash flow is up +15.03% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
RAPT annual gross profit margin value is unknown

Operating margin

-
RAPT annual operating profit margin value is unknown

Net margin

-
RAPT annual net profit margin value is unknown

ROA & ROE

ROA

-54.04%
RAPT annual return on assets is -54.04%

ROE

-68.38%
RAPT annual return on equity is -68.38%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
RAPT price to earnings ratio value is unknown

PE ratio Sector rank

-
RAPT price to earnings ratio is unknown

PB Ratio

PB ratio

0.60
RAPT price to book ratio is 0.60

PB ratio Sector rank

32.84%
RAPT price to book ratio is higher than 32.84% of companies in Healthcare sector

PS Ratio

PS ratio

-
RAPT price to sales ratio value is unknown

PS ratio Sector rank

-
RAPT price to sales ratio is unknown

Enterprise value

Enterprise value

-$52.11M
RAPT enterprise value is -$52.11 million

Enterprise value Sector rank

1.49%
RAPT enterprise value is higher than 1.49% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

0.39
RAPT EV/EBITDA is 0.39

EV/EBITDA Sector rank

71.02%
RAPT EV/EBITDA is higher than 71.02% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

4.87
RAPT annual current ratio is 4.87

Quick ratio

-
RAPT annual quick ratio value is unknown

Leverage

Debt to equity

0.02
RAPT annual debt to equity ratio is 0.02

Interest coverage ratio

-
RAPT annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
RAPT piotroski f-score value is unknown

Altman Z-Score

-
RAPT altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Mar 10, 25 HC Wainwright & Co.
Buy
Dec 26, 24 HC Wainwright & Co.
Buy
Nov 25, 24 HC Wainwright & Co.
Neutral
Nov 12, 24 Wells Fargo
Overweight
Nov 12, 24 HC Wainwright & Co.
Neutral
Nov 11, 24 JP Morgan
Underweight
Sep 9, 24 UBS
Neutral
Aug 20, 24 HC Wainwright & Co.
Neutral
Jul 23, 24 HC Wainwright & Co.
Neutral
May 14, 24 Wolfe Research
Peer Perform

Institutional Ownership

Similar stocks

ZTEK logo
Zentek (ZTEK)
EDIT logo
Editas Medicine (EDIT)
CSBR logo
Champions Oncology (CSBR)
AMWL logo
American Well (AMWL)
BioAge Labs (BIOA)
Anteris Technologies Global (AVR)
KRMD logo
KORU Medical Systems (KRMD)
ENTA logo
Enanta Pharmaceuticals (ENTA)
IRWD logo
Ironwood Pharmaceuticals (IRWD)
  • What is the ticker symbol for RAPT Therapeutics?
  • Does RAPT Therapeutics pay dividends?
  • What sector is RAPT Therapeutics in?
  • What industry is RAPT Therapeutics in?
  • What country is RAPT Therapeutics based in?
  • When did RAPT Therapeutics go public?
  • Is RAPT Therapeutics in the S&P 500?
  • Is RAPT Therapeutics in the NASDAQ 100?
  • Is RAPT Therapeutics in the Dow Jones?
  • When was RAPT Therapeutics's last earnings report?
  • When does RAPT Therapeutics report earnings?
  • Should I buy RAPT Therapeutics stock now?

What is the ticker symbol for RAPT Therapeutics?

The ticker symbol for RAPT Therapeutics is NASDAQ:RAPT

Does RAPT Therapeutics pay dividends?

No, RAPT Therapeutics does not pay dividends

What sector is RAPT Therapeutics in?

RAPT Therapeutics is in the Healthcare sector

What industry is RAPT Therapeutics in?

RAPT Therapeutics is in the Biotechnology industry

What country is RAPT Therapeutics based in?

RAPT Therapeutics is headquartered in United States

When did RAPT Therapeutics go public?

RAPT Therapeutics's initial public offering (IPO) was on October 31, 2019

Is RAPT Therapeutics in the S&P 500?

No, RAPT Therapeutics is not included in the S&P 500 index

Is RAPT Therapeutics in the NASDAQ 100?

No, RAPT Therapeutics is not included in the NASDAQ 100 index

Is RAPT Therapeutics in the Dow Jones?

No, RAPT Therapeutics is not included in the Dow Jones index

When was RAPT Therapeutics's last earnings report?

RAPT Therapeutics's most recent earnings report was on Mar 6, 2025

When does RAPT Therapeutics report earnings?

The next expected earnings date for RAPT Therapeutics is May 9, 2025

Should I buy RAPT Therapeutics stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page